Share Price and Basic Stock Data
Last Updated: November 18, 2025, 3:36 am
| PEG Ratio | -2.33 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Vinyl Chemicals (I) Ltd reported a market capitalization of ₹512 Cr and a current share price of ₹279. The company has shown considerable growth in its revenue, with sales rising from ₹865 Cr in FY 2022 to ₹1,013 Cr in FY 2023. However, there was a notable decline in revenue in FY 2024, which stood at ₹597 Cr, reflecting a decrease in operational performance. The trailing twelve months (TTM) revenue is reported at ₹621 Cr, indicating a slight recovery from the previous fiscal year. Quarterly sales trends show fluctuations, with the highest quarterly sales recorded at ₹324.17 Cr in September 2022 and a dip to ₹106.93 Cr in March 2023. Recent quarters have shown a recovery, with June 2025 sales reported at ₹151.23 Cr. This inconsistency highlights the company’s vulnerability to market conditions, but the recent uptick suggests potential stabilization in demand.
Profitability and Efficiency Metrics
The profitability metrics of Vinyl Chemicals (I) Ltd reveal a mixed performance. The company reported a net profit of ₹36 Cr for FY 2023, which declined to ₹22 Cr in FY 2024 but remained stable at ₹22 Cr for FY 2025. The operating profit margin (OPM) has fluctuated significantly, peaking at 5% in FY 2024 before dropping to 4% in FY 2025. The return on equity (ROE) stood at 15.6%, while the return on capital employed (ROCE) was reported at 21.1%. The interest coverage ratio (ICR) is exceptionally high at 763.53x, indicating robust operational profitability relative to interest obligations, which is a significant strength. However, the operating profit has been inconsistent, with a notable drop in OPM to 1.30% in the recent quarter, reflecting challenges in maintaining cost efficiency amid fluctuating sales.
Balance Sheet Strength and Financial Ratios
Vinyl Chemicals (I) Ltd displays a strong balance sheet characterized by no borrowings, which is a notable advantage, as it minimizes financial risk. The company reported reserves of ₹125 Cr as of FY 2025, reflecting a solid capital base. The current ratio stands at 1.93, indicating adequate liquidity to meet short-term obligations. However, the price-to-book value (P/BV) ratio is relatively high at 4.10x, suggesting that the stock may be overvalued compared to its book value of ₹69.05 per share. The net profit margin was reported at 3.57% in FY 2025, which is low compared to typical industry standards, indicating potential challenges in pricing power or cost management. Overall, while the balance sheet is strong, the high P/BV ratio and low profit margin raise questions about valuation and profitability sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vinyl Chemicals (I) Ltd demonstrates a stable promoter holding of 50.41%, which has remained consistent over the past several quarters. This stability can foster investor confidence, as it indicates a strong commitment from the management. The presence of foreign institutional investors (FIIs) has been negligible, with reported holdings of 0% in recent quarters, which could reflect a lack of international interest in the stock. Domestic institutional investors (DIIs) hold only 0.02%, suggesting limited institutional backing. The total number of shareholders has declined from 42,945 in December 2022 to 40,756 by March 2025, indicating a potential reduction in retail investor interest. This decline may raise concerns regarding overall market perception and could impact liquidity and stock performance in the future.
Outlook, Risks, and Final Insight
The outlook for Vinyl Chemicals (I) Ltd hinges on its ability to stabilize revenue and improve profitability metrics. Key strengths include a strong balance sheet with no debt and high interest coverage, which provide a solid foundation for operational flexibility. However, risks persist, including fluctuating sales and declining profit margins, which may impact investor sentiment. Additionally, the lack of institutional support may hinder the stock’s ability to attract larger investments. The company must focus on enhancing operational efficiency and maintaining consistent revenue growth to bolster investor confidence. If management successfully navigates these challenges, the stock could see a recovery in investor interest and valuation. Conversely, failure to address these issues may lead to further declines in market perception and financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vinyl Chemicals (I) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 124 Cr. | 32.2 | 869/26.8 | 1.20 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,740 Cr. | 172 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 48.1 Cr. | 3.77 | 8.90/3.55 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,860.22 Cr | 232.49 | 386.67 | 219.06 | 0.23% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310.75 | 324.17 | 270.66 | 106.93 | 115.31 | 154.40 | 159.03 | 168.27 | 155.63 | 150.34 | 146.40 | 172.88 | 151.23 |
| Expenses | 301.06 | 311.30 | 260.62 | 97.41 | 111.87 | 149.87 | 150.28 | 159.63 | 149.65 | 144.39 | 142.74 | 162.93 | 149.26 |
| Operating Profit | 9.69 | 12.87 | 10.04 | 9.52 | 3.44 | 4.53 | 8.75 | 8.64 | 5.98 | 5.95 | 3.66 | 9.95 | 1.97 |
| OPM % | 3.12% | 3.97% | 3.71% | 8.90% | 2.98% | 2.93% | 5.50% | 5.13% | 3.84% | 3.96% | 2.50% | 5.76% | 1.30% |
| Other Income | 5.00 | 0.70 | 0.16 | 0.99 | 1.26 | 0.82 | 0.64 | 1.73 | 0.78 | 1.05 | 2.99 | 0.19 | 4.09 |
| Interest | 0.09 | 0.15 | 0.17 | 0.94 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
| Profit before tax | 14.58 | 13.39 | 10.01 | 9.54 | 4.66 | 5.31 | 9.36 | 10.33 | 6.73 | 6.95 | 6.61 | 10.11 | 6.02 |
| Tax % | 25.10% | 24.94% | 26.37% | 23.48% | 24.89% | 26.93% | 25.96% | 27.11% | 26.89% | 26.19% | 24.21% | 28.09% | 26.08% |
| Net Profit | 10.92 | 10.05 | 7.37 | 7.30 | 3.50 | 3.88 | 6.93 | 7.53 | 4.92 | 5.13 | 5.01 | 7.27 | 4.45 |
| EPS in Rs | 5.96 | 5.48 | 4.02 | 3.98 | 1.91 | 2.12 | 3.78 | 4.11 | 2.68 | 2.80 | 2.73 | 3.96 | 2.43 |
Last Updated: August 1, 2025, 9:25 am
Below is a detailed analysis of the quarterly data for Vinyl Chemicals (I) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 151.23 Cr.. The value appears to be declining and may need further review. It has decreased from 172.88 Cr. (Mar 2025) to 151.23 Cr., marking a decrease of 21.65 Cr..
- For Expenses, as of Jun 2025, the value is 149.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 162.93 Cr. (Mar 2025) to 149.26 Cr., marking a decrease of 13.67 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.97 Cr.. The value appears to be declining and may need further review. It has decreased from 9.95 Cr. (Mar 2025) to 1.97 Cr., marking a decrease of 7.98 Cr..
- For OPM %, as of Jun 2025, the value is 1.30%. The value appears to be declining and may need further review. It has decreased from 5.76% (Mar 2025) to 1.30%, marking a decrease of 4.46%.
- For Other Income, as of Jun 2025, the value is 4.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 4.09 Cr., marking an increase of 3.90 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.02 Cr.. The value appears to be declining and may need further review. It has decreased from 10.11 Cr. (Mar 2025) to 6.02 Cr., marking a decrease of 4.09 Cr..
- For Tax %, as of Jun 2025, the value is 26.08%. The value appears to be improving (decreasing) as expected. It has decreased from 28.09% (Mar 2025) to 26.08%, marking a decrease of 2.01%.
- For Net Profit, as of Jun 2025, the value is 4.45 Cr.. The value appears to be declining and may need further review. It has decreased from 7.27 Cr. (Mar 2025) to 4.45 Cr., marking a decrease of 2.82 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.43. The value appears to be declining and may need further review. It has decreased from 3.96 (Mar 2025) to 2.43, marking a decrease of 1.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 442 | 335 | 293 | 375 | 483 | 372 | 404 | 865 | 1,013 | 597 | 625 | 622 |
| Expenses | 282 | 424 | 326 | 283 | 361 | 469 | 366 | 389 | 821 | 966 | 572 | 600 | 604 |
| Operating Profit | 10 | 18 | 9 | 9 | 14 | 14 | 6 | 15 | 44 | 47 | 25 | 26 | 18 |
| OPM % | 4% | 4% | 3% | 3% | 4% | 3% | 2% | 4% | 5% | 5% | 4% | 4% | 3% |
| Other Income | 1 | 1 | 3 | 4 | 4 | 1 | 4 | 0 | 2 | 2 | 4 | 5 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 11 | 19 | 12 | 13 | 18 | 14 | 10 | 15 | 47 | 48 | 30 | 30 | 27 |
| Tax % | 34% | 34% | 35% | 35% | 36% | 37% | 25% | 26% | 25% | 25% | 26% | 27% | |
| Net Profit | 7 | 12 | 8 | 9 | 12 | 9 | 7 | 11 | 35 | 36 | 22 | 22 | 20 |
| EPS in Rs | 4.08 | 6.73 | 4.36 | 4.76 | 6.36 | 4.83 | 4.07 | 6.19 | 19.01 | 19.44 | 11.91 | 12.18 | 10.69 |
| Dividend Payout % | 24% | 22% | 34% | 38% | 38% | 50% | 59% | 60% | 52% | 51% | 57% | 57% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 71.43% | -33.33% | 12.50% | 33.33% | -25.00% | -22.22% | 57.14% | 218.18% | 2.86% | -38.89% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -104.76% | 45.83% | 20.83% | -58.33% | 2.78% | 79.37% | 161.04% | -215.32% | -41.75% | 38.89% |
Vinyl Chemicals (I) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | -10% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | -17% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 25% |
| 3 Years: | -18% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 40 | 54 | 57 | 75 | 48 | 45 | 100 | 5 | 11 | 65 | 61 |
| Inventory Days | 48 | 33 | 29 | 23 | 57 | 53 | 50 | 70 | 24 | 33 | 78 | 39 |
| Days Payable | 99 | 53 | 88 | 69 | 116 | 63 | 95 | 188 | 26 | 22 | 118 | 78 |
| Cash Conversion Cycle | 15 | 20 | -5 | 11 | 17 | 39 | -1 | -17 | 3 | 22 | 25 | 23 |
| Working Capital Days | 16 | 19 | -4 | 10 | 19 | 36 | 2 | 2 | 7 | 26 | 32 | 27 |
| ROCE % | 45% | 57% | 24% | 21% | 30% | 24% | 14% | 23% | 55% | 44% | 22% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Diluted EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Cash EPS (Rs.) | 12.23 | 11.96 | 19.49 | 19.01 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Dividend / Share (Rs.) | 7.00 | 6.75 | 10.00 | 10.00 | 3.75 |
| Revenue From Operations / Share (Rs.) | 340.85 | 325.45 | 551.96 | 471.58 | 220.32 |
| PBDIT / Share (Rs.) | 16.65 | 16.25 | 26.70 | 25.54 | 8.34 |
| PBIT / Share (Rs.) | 16.59 | 16.20 | 26.64 | 25.54 | 8.34 |
| PBT / Share (Rs.) | 16.57 | 16.17 | 25.91 | 25.45 | 8.31 |
| Net Profit / Share (Rs.) | 12.17 | 11.91 | 19.43 | 19.01 | 6.19 |
| PBDIT Margin (%) | 4.88 | 4.99 | 4.83 | 5.41 | 3.78 |
| PBIT Margin (%) | 4.86 | 4.97 | 4.82 | 5.41 | 3.78 |
| PBT Margin (%) | 4.86 | 4.96 | 4.69 | 5.39 | 3.77 |
| Net Profit Margin (%) | 3.57 | 3.65 | 3.52 | 4.03 | 2.80 |
| Return on Networth / Equity (%) | 17.63 | 18.70 | 31.45 | 36.30 | 16.67 |
| Return on Capital Employeed (%) | 23.89 | 25.29 | 42.84 | 48.43 | 22.12 |
| Return On Assets (%) | 8.51 | 7.15 | 20.29 | 21.56 | 4.22 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 2.20 | 2.48 | 6.00 | 4.02 | 1.90 |
| Current Ratio (X) | 1.93 | 1.62 | 2.83 | 2.47 | 1.34 |
| Quick Ratio (X) | 1.46 | 0.97 | 1.46 | 1.66 | 0.97 |
| Dividend Payout Ratio (NP) (%) | 55.42 | 83.94 | 51.44 | 19.72 | 38.76 |
| Dividend Payout Ratio (CP) (%) | 55.17 | 83.55 | 51.29 | 19.72 | 38.74 |
| Earning Retention Ratio (%) | 44.58 | 16.06 | 48.56 | 80.28 | 61.24 |
| Cash Earning Retention Ratio (%) | 44.83 | 16.45 | 48.71 | 80.28 | 61.26 |
| Interest Coverage Ratio (X) | 763.53 | 611.00 | 36.23 | 283.98 | 329.54 |
| Interest Coverage Ratio (Post Tax) (X) | 559.34 | 448.62 | 27.37 | 212.29 | 245.55 |
| Enterprise Value (Cr.) | 507.69 | 574.53 | 612.80 | 480.31 | 201.52 |
| EV / Net Operating Revenue (X) | 0.81 | 0.96 | 0.60 | 0.55 | 0.49 |
| EV / EBITDA (X) | 16.62 | 19.27 | 12.51 | 10.25 | 13.17 |
| MarketCap / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| Retention Ratios (%) | 44.57 | 16.05 | 48.55 | 80.27 | 61.23 |
| Price / BV (X) | 4.10 | 4.97 | 5.42 | 5.01 | 3.13 |
| Price / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.07 | 0.05 |
After reviewing the key financial ratios for Vinyl Chemicals (I) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 11.96 (Mar 24) to 12.23, marking an increase of 0.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 6.75 (Mar 24) to 7.00, marking an increase of 0.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 340.85. It has increased from 325.45 (Mar 24) to 340.85, marking an increase of 15.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 16.25 (Mar 24) to 16.65, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.59. This value is within the healthy range. It has increased from 16.20 (Mar 24) to 16.59, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.57. This value is within the healthy range. It has increased from 16.17 (Mar 24) to 16.57, marking an increase of 0.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has decreased from 4.99 (Mar 24) to 4.88, marking a decrease of 0.11.
- For PBIT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.97 (Mar 24) to 4.86, marking a decrease of 0.11.
- For PBT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.96 (Mar 24) to 4.86, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 5. It has decreased from 3.65 (Mar 24) to 3.57, marking a decrease of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.63. This value is within the healthy range. It has decreased from 18.70 (Mar 24) to 17.63, marking a decrease of 1.07.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.89. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 23.89, marking a decrease of 1.40.
- For Return On Assets (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 8.51, marking an increase of 1.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.20. It has decreased from 2.48 (Mar 24) to 2.20, marking a decrease of 0.28.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 1.93, marking an increase of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.46, marking an increase of 0.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.42. This value exceeds the healthy maximum of 50. It has decreased from 83.94 (Mar 24) to 55.42, marking a decrease of 28.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 55.17. This value exceeds the healthy maximum of 50. It has decreased from 83.55 (Mar 24) to 55.17, marking a decrease of 28.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.58. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 44.58, marking an increase of 28.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 16.45 (Mar 24) to 44.83, marking an increase of 28.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 763.53. This value is within the healthy range. It has increased from 611.00 (Mar 24) to 763.53, marking an increase of 152.53.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 559.34. This value is within the healthy range. It has increased from 448.62 (Mar 24) to 559.34, marking an increase of 110.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 507.69. It has decreased from 574.53 (Mar 24) to 507.69, marking a decrease of 66.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.81, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 16.62. This value exceeds the healthy maximum of 15. It has decreased from 19.27 (Mar 24) to 16.62, marking a decrease of 2.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 44.57. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 44.57, marking an increase of 28.52.
- For Price / BV (X), as of Mar 25, the value is 4.10. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 4.10, marking a decrease of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinyl Chemicals (I) Ltd:
- Net Profit Margin: 3.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.89% (Industry Average ROCE: 11.01%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.63% (Industry Average ROE: 20.11%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 559.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.3 (Industry average Stock P/E: 213.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Regent Chambers, 7th Floor, Mumbai Maharashtra 400021 | cs.vinylchemicals@pidilite.com http://www.vinylchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M B Parekh | Chairman & Managing Director |
| Mr. N K Parekh | Director |
| Mr. A B Parekh | Director |
| Mr. P D Shah | Director |
| Mr. L Viswanathan | Director |
| Mrs. Shailashri Bhaskar | Director |